CRBU Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Caribou Biosciences Insider Trading History Chart

Caribou Biosciences Share Price & Price History

^$3.72

▼ -0.04 (-1.06%)

As of 04/26/2024 04:45 PM ET

Days: 30 | 90 | 365

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

Caribou Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2023	Syed Ali-Aamir Rizvi	Insider	Sell	5,627	$6.31	$35,506.37	59,373
10/6/2022	Ryan Fischesser	VP	Sell	10,000	$10.80	$108,000.00	110,366
8/25/2022	Steven Kanner	Insider	Sell	43,248	$11.22	$485,242.56	302,059
1/11/2022	Ryan Fischesser	VP	Buy	7,387	$4.00	$29,548.00
12/20/2021	Ryan Fischesser	VP	Buy	1,136	$2.69	$3,055.84
12/7/2021	Barbara G. McClung	Insider	Buy	6,127	$2.69	$16,481.63
10/20/2021	Barbara G. McClung	Insider	Buy	9,219	$2.69	$24,799.11
10/12/2021	Steven Kanner	Insider	Buy	114,860	$1.92	$220,531.20
10/11/2021	Ryan Fischesser	VP	Buy	1,746	$2.69	$4,696.74

Protect Yourself While There’s Still Time …

From Weiss Ratings | Ad

4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Caribou Biosciences (NASDAQ:CRBU)

77.51% of Caribou Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Caribou Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	26,592	$0.14M	0.0%	-98.8%	0.029%
4/18/2024	Allspring Global Investments Holdings LLC	42,653	$0.22M	0.0%	+9.2%	0.047%
4/10/2024	Green Alpha Advisors LLC	83,521	$0.43M	0.3%	+5.0%	0.092%
3/5/2024	Wellington Management Group LLP	314,080	$1.80M	0.0%	+57.7%	0.355%
2/15/2024	PFM Health Sciences LP	6,480,764	$37.14M	2.2%	-3.6%	7.329%
2/14/2024	Avidity Partners Management LP	6,360,212	$36.44M	1.3%	+5.1%	7.192%
2/14/2024	Pale Fire Capital SE	28,200	$0.16M	0.0%	N/A	0.032%
2/14/2024	Westwood Holdings Group Inc.	277,205	$1.59M	0.0%	+81.9%	0.313%
2/13/2024	Rafferty Asset Management LLC	381,198	$2.18M	0.0%	-24.9%	0.431%
2/9/2024	Trexquant Investment LP	11,152	$64K	0.0%	-94.8%	0.013%
2/9/2024	Dynamic Technology Lab Private Ltd	35,174	$0.20M	0.0%	N/A	0.040%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	44,202	$0.25M	0.0%	N/A	0.050%
2/7/2024	E Fund Management Co. Ltd.	20,351	$0.12M	0.0%	-21.9%	0.023%
2/1/2024	New York State Common Retirement Fund	34,249	$0.20M	0.0%	+122.6%	0.039%
1/31/2024	abrdn plc	181,487	$1.04M	0.0%	N/A	0.205%
1/31/2024	Resonant Capital Advisors LLC	184,198	$1.06M	0.1%	N/A	0.208%
1/25/2024	Allspring Global Investments Holdings LLC	39,059	$0.22M	0.0%	N/A	0.044%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	173,606	$1M	0.0%	-40.5%	0.196%
1/24/2024	DekaBank Deutsche Girozentrale	130,000	$0.76M	0.0%	N/A	0.147%
1/24/2024	Prime Capital Investment Advisors LLC	17,676	$0.10M	0.0%	-51.5%	0.020%
1/24/2024	China Universal Asset Management Co. Ltd.	10,226	$59K	0.0%	+352.9%	0.012%
1/17/2024	Assenagon Asset Management S.A.	2,258,539	$12.94M	0.0%	-14.7%	2.554%
1/16/2024	Raymond James Financial Services Advisors Inc.	26,252	$0.15M	0.0%	N/A	0.030%
1/16/2024	Raymond James & Associates	114,864	$0.66M	0.0%	-13.3%	0.130%
1/12/2024	SG Americas Securities LLC	39,577	$0.23M	0.0%	N/A	0.045%
1/10/2024	Thrive Wealth Management LLC	32,000	$0.18M	0.0%	N/A	0.036%
1/5/2024	Exchange Traded Concepts LLC	23,924	$0.14M	0.0%	+34.0%	0.027%
1/5/2024	Green Alpha Advisors LLC	79,564	$0.46M	0.3%	-28.0%	0.090%
12/18/2023	Vanguard Group Inc.	3,822,151	$18.27M	0.0%	+49.3%	4.322%
11/21/2023	Walleye Capital LLC	468,127	$2.24M	0.0%	-5.3%	0.529%
11/15/2023	Kynam Capital Management LP	1,068,527	$5.11M	0.8%	N/A	1.208%
11/15/2023	Laurion Capital Management LP	165,192	$0.79M	0.0%	N/A	0.187%
11/15/2023	Alkeon Capital Management LLC	1,644,863	$7.86M	0.0%	+21.2%	1.860%
11/15/2023	Stansberry Asset Management LLC	77,232	$0.37M	0.1%	+8.0%	0.087%
11/14/2023	Deerfield Management Company L.P. Series C	3,500,000	$16.73M	0.4%	N/A	3.958%
11/14/2023	Avidity Partners Management LP	6,050,212	$28.92M	1.2%	+119.3%	6.842%
11/14/2023	Trexquant Investment LP	214,144	$1.02M	0.0%	+141.0%	0.242%
11/14/2023	Mutual Advisors LLC	17,366	$83K	0.0%	N/A	0.020%
11/14/2023	Profund Advisors LLC	84,899	$0.41M	0.0%	N/A	0.096%
11/13/2023	Silverarc Capital Management LLC	892,786	$4.27M	1.3%	N/A	1.010%
11/13/2023	Rafferty Asset Management LLC	507,400	$2.43M	0.0%	N/A	0.574%
11/13/2023	E Fund Management Co. Ltd.	26,065	$0.13M	0.0%	N/A	0.029%
11/9/2023	Citigroup Inc.	221,166	$1.06M	0.0%	+739.3%	0.250%
11/9/2023	Prime Capital Investment Advisors LLC	36,463	$0.17M	0.0%	-9.6%	0.041%
11/8/2023	State Board of Administration of Florida Retirement System	21,320	$0.10M	0.0%	+32.0%	0.024%
11/7/2023	Virtus ETF Advisers LLC	21,358	$0.10M	0.1%	-9.1%	0.024%
11/7/2023	Barclays PLC	254,231	$1.22M	0.0%	+1,296.0%	0.288%
11/7/2023	Jump Financial LLC	92,204	$0.44M	0.0%	N/A	0.104%
11/6/2023	Assenagon Asset Management S.A.	2,648,582	$12.66M	0.0%	+247.5%	3.000%
11/2/2023	Principal Financial Group Inc.	25,198	$0.12M	0.0%	+32.8%	0.029%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	291,891	$1.40M	0.0%	+16.0%	0.331%
10/24/2023	Bank of New York Mellon Corp	264,243	$1.26M	0.0%	+29.5%	0.299%
10/24/2023	Raymond James & Associates	132,422	$0.63M	0.0%	-37.1%	0.150%
10/18/2023	Exchange Traded Concepts LLC	17,858	$85K	0.0%	-38.6%	0.020%
10/10/2023	Green Alpha Advisors LLC	110,524	$0.53M	0.4%	+4.4%	0.125%
9/21/2023	Baystate Wealth Management LLC	12,903	$55K	0.0%	N/A	0.015%
8/14/2023	Granahan Investment Management LLC	126,297	$0.54M	0.0%	+3.8%	0.206%
8/14/2023	Prelude Capital Management LLC	23,900	$0.10M	0.0%	N/A	0.039%
8/11/2023	SVB Financial Group	20,714	$88K	0.2%	-25.0%	0.034%
8/11/2023	Stansberry Asset Management LLC	253,552	$0.30M	0.1%	+257.8%	0.413%
8/11/2023	Trexquant Investment LP	88,867	$0.38M	0.0%	N/A	0.145%
8/11/2023	Penserra Capital Management LLC	25,223	$0.11M	0.0%	+33.5%	0.041%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	251,669	$1.07M	0.0%	+12.7%	0.410%
8/7/2023	Principal Financial Group Inc.	18,971	$81K	0.0%	+20.1%	0.031%
8/2/2023	Baystate Wealth Management LLC	12,903	$55K	0.0%	N/A	0.021%
7/25/2023	Raymond James & Associates	210,586	$0.90M	0.0%	+287.2%	0.343%
7/25/2023	Assenagon Asset Management S.A.	762,098	$3.24M	0.0%	-9.6%	1.242%
7/20/2023	Exchange Traded Concepts LLC	29,068	$0.12M	0.0%	N/A	0.047%
7/6/2023	Green Alpha Advisors LLC	105,826	$0.45M	0.3%	+25.3%	0.172%
5/23/2023	Royce & Associates LP	14,700	$78K	0.0%	+38.7%	0.024%
5/18/2023	International Biotechnology Trust PLC	457,892	$2.43M	0.7%	+77.6%	0.746%
5/12/2023	Bruce & Co. Inc.	100,000	$0.53M	0.1%	N/A	0.163%
5/12/2023	Long Focus Capital Management LLC	48,750	$0.26M	0.0%	-25.0%	0.079%
5/11/2023	RMB Capital Management LLC	74,629	$0.40M	0.0%	+41.4%	0.122%
5/11/2023	E Fund Management Co. Ltd.	13,274	$70K	0.0%	+19.7%	0.022%
5/10/2023	Pictet Asset Management SA	2,066,176	$10.97M	0.0%	-19.1%	3.368%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	79,150	$0.42M	0.0%	+78.4%	0.129%
5/5/2023	Prime Capital Investment Advisors LLC	26,331	$0.14M	0.0%	N/A	0.043%
5/4/2023	Barclays PLC	101,192	$0.54M	0.0%	-15.7%	0.165%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	223,237	$1.19M	0.0%	+5.0%	0.364%
5/4/2023	Royce & Associates LP	14,700	$78K	0.0%	+38.7%	0.024%
5/3/2023	Jump Financial LLC	27,200	$0.14M	0.0%	-36.2%	0.044%
4/28/2023	SG Americas Securities LLC	22,295	$0.12M	0.0%	-12.1%	0.036%
4/24/2023	Penserra Capital Management LLC	18,890	$100K	0.0%	+34.9%	0.031%
4/18/2023	Assenagon Asset Management S.A.	843,025	$4.48M	0.0%	-1.4%	1.375%
4/14/2023	Raymond James & Associates	54,382	$0.29M	0.0%	N/A	0.089%
4/6/2023	Green Alpha Advisors LLC	84,467	$0.45M	0.3%	+12.5%	0.138%
2/15/2023	Alkeon Capital Management LLC	1,058,603	$6.65M	0.0%	-13.4%	1.735%
2/15/2023	Avidity Partners Management LP	2,882,600	$18.10M	0.4%	-9.1%	4.726%
2/14/2023	Alpine Global Management LLC	17,442	$0.11M	0.0%	N/A	0.029%
2/14/2023	Granahan Investment Management LLC	230,341	$1.45M	0.0%	-3.3%	0.378%
2/13/2023	Shelton Capital Management	160,700	$1.01M	0.1%	-7.0%	0.263%
2/13/2023	Boulder Hill Capital Management LP	11,400	$72K	0.1%	N/A	0.019%
2/13/2023	Cornercap Investment Counsel Inc.	37,625	$0.24M	0.0%	N/A	0.062%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	44,361	$0.28M	0.0%	N/A	0.073%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	212,651	$1.34M	0.0%	-15.5%	0.349%
2/9/2023	Citigroup Inc.	103,108	$0.65M	0.0%	-19.8%	0.169%
2/8/2023	Swiss National Bank	117,500	$0.74M	0.0%	+2.7%	0.193%
2/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	27,681	$0.18M	0.0%	N/A	0.045%
2/2/2023	SG Americas Securities LLC	25,369	$0.16M	0.0%	+8.2%	0.042%

Data available starting January 2016

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Today's Range

Now: $3.72

$3.69

$3.90

50 Day Range

MA: $5.59

$3.76

$8.26

52 Week Range

Now: $3.72

$3.44

$8.59

Volume

619,672 shs

Average Volume

1,613,157 shs

Market Capitalization

$335.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.47

Who are the company insiders with the largest holdings of Caribou Biosciences?: Caribou Biosciences' top insider shareholders include:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Syed Ali-Aamir Rizvi (Insider)
Learn More about top insider investors at Caribou Biosciences.
Who are the major institutional investors of Caribou Biosciences?: Caribou Biosciences' top institutional shareholders include:
Green Alpha Advisors LLC — 0.09%
Allspring Global Investments Holdings LLC — 0.05%
Assenagon Asset Management S.A. — 0.03%
Learn More about top institutional investors of Caribou Biosciences stock.
Which institutional investors are selling Caribou Biosciences stock?: In the last quarter, CRBU stock was sold by these institutional investors:
Assenagon Asset Management S.A.
Which institutional investors are buying Caribou Biosciences stock?: During the previous quarter, CRBU stock was bought by institutional investors including:
Green Alpha Advisors LLC
Allspring Global Investments Holdings LLC